跳至主要内容
临床试验/NCT01012856
NCT01012856Unknown2 期

Explicit and Implicit Change of Depression in Exposure-based Cognitive Therapy

University of Zurich1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2010年1月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
142
试验地点
1
主要终点
severity of depressive symptoms measured by the Beck-Depression-Inventory (BDI-II)

研究概览

简要总结

The purpose of this study is to investigate, if exposure-based cognitive therapy (EBCT) is at least as effective as the established cognitive-behavioral therapy and more effective in its long-term efficacy. Moreover the mechanisms of change of the EBCT are investigated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Major Depressive Disorder according to DSM-IV as main diagnosis
  • •minimum standardized depression scores (BDI >= 17; HAMD >=13)
  • •minimum age of 18 years
  • •informed consent to participate voluntarily in the study
  • •sufficient German language skills

排除标准

  • •acute suicidality
  • •depressive disorder with mood-incongruent psychotic features
  • •chronic depressive disorder
  • •organic cause of depression
  • •drug-induced depression
  • •bipolar disorder
  • •diagnosis of schizophrenia, schizophreniform, schizoaffective disorders, and/or psychosis NOS
  • •comorbid dysthymia, psychotic disorder (acute or anamnestic), dementia, substance dependence, schizotypal/ borderline/ or antisocial personality disorder
  • •psychopharmacological treatment other than antidepressants
  • •antidepressant medication, if it is changed within one month prior to the beginning of psychotherapy
  • •other simultaneous psychological treatments

研究组 & 干预措施

Cognitive-Behavioral Therapy for Depression (CBT)

Active Comparator

干预措施: Cognitive-Behavioral Therapy for Depression (Behavioral)

Exposure-Based Cognitive Therapy for Depression (EBCT)

Experimental

干预措施: Exposure-Based Cognitive Therapy for Depression (Behavioral)

结局指标

主要结局

severity of depressive symptoms measured by the Beck-Depression-Inventory (BDI-II)

时间窗: end of therapy, 6 month after end of therapy (follow up)

次要结局

  • symptom impairment measured by the Brief Symptom Inventory (BSI)(end of therapy, 6-month follow up)
  • quality of life measured by the WHO Quality of Life-BREF (WHOQOL-BREF)(end of therapy, 6-month follow-up)
  • interpersonal problems measured by the Inventory of Interpersonal Problems (IIP)(end of therapy, 6-month follow-up)
  • avoidance measured by the Cognitive-Behavioral Avoidance Scales (CBAS)(end of therapy, 6-month follow-up)
  • resources measured by the Bernese Inventory of Resources (RES-K)(end of therapy, 6-month follow-up)
  • explicit self-esteem measured by the Rosenberg self-esteem scale (RSES)(end of therapy, 6-month follow up)
  • implicit self-esteem measured by the Self-Esteem Implicit Association Test (SE-IAT)(end of therapy)
  • goal attainment measured by Goal Attainment Scaling (GAS)(end of therapy)
  • avoidance motivation measured by the Inventory of Approach and Avoidance Motivation (IAAM)(end of therpy, 6-month follow-up)
  • motivational incongruence measured by The Incongruence Questionnaire (INC)(end of therapy, 6-month follow-up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验